AGT and chronic kidney disease: Indeed, regression of proteinuria and renal fibrosis by blocking the RAS action has been reported in some experimental models of CKD in rodents, such as chronic nitric oxide deficiency, infusion of AngII by osmotic minipumps, nephrectomy or puromycin aminonucleoside [6], [14]–[16].